// STATE LEGISLATION TRACKER

Pennsylvania HB 773: An Act amending Title 23 (Domestic Relations) of the Pennsylvania Consolidated Statutes, in child protective services, f

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Failed

State: Pennsylvania
Bill: HB 773
Filed: 2019-03-11
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Pennsylvania HB 773 appears to deal with child protective services notifications and plans of safe care for children under one year old. Based on the title and available status information, it does not address compounded peptides, off-label prescribing, telehealth, clinician scope, FDA compounding rules, controlled substance scheduling, or prescription monitoring.

Key Points

No apparent change to peptide prescribing or access
No apparent change to 503A or 503B compounding rules
No apparent change to telehealth prescribing
No apparent change to NP or naturopathic scope
Clinicians should treat it as child-safety reporting policy, not peptide policy

What to Watch For

Note The bill is about child protective services, not peptide treatment or compounding.

Note It may matter to clinicians involved in infant care or substance-exposure reporting.

Note No peptide-specific compliance action appears needed from the available title and status.

Where the Bill Stands

The bill was referred to the House Children and Youth Committee on March 11, 2019, and the 2019-2020 session has ended without enactment.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws